Two Sigma Securities’s United Therapeutics UTHR Stock Holding History

Two Sigma Securities’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,900	Closed	-$1.4M	–	3241
2024 Q3	$1.4M	Sell	3,900 -15,900	-80%	-$5.37M	0.02%	715
2024 Q2	$6.31M	Buy	19,800 +12,100	+157%	+$3.2M	0.08%	292
2024 Q1	$1.77M	Buy	+7,700	New	+$1.74M	0.02%	817
2023 Q4	–	Sell	-5,100	Closed	-$1.15M	–	3620
2023 Q3	$1.15M	Buy	5,100 +2,800	+122%	+$645K	0.01%	950
2023 Q2	$508K	Buy	2,300 +300	+15%	+$66.5K	0.01%	1423
2023 Q1	$448K	Sell	2,000 -200	-9%	-$49.3K	0.01%	1342
2022 Q4	$612K	Buy	+2,200	New	+$555K	0.02%	955
2019 Q2	–	Sell	-3,400	Closed	-$399K	–	2437
2019 Q1	$399K	Buy	+3,400	New	+$396K	﹤0.01%	1007

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Securities's UTHR Position: Q1 2026 in Review

Two Sigma Securities opened a new position in United Therapeutics (UTHR) in Q1 2026: 510 shares worth $302K. The stake represents 0.04% of the portfolio and ranks #771 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in UTHR as recently as Q3 2025.

Two Sigma Securities first reported a position in UTHR in Q3 2015 and has held it in 15 quarters since. The position peaked at $1.17M in Q3 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Two Sigma Securities held 510 shares of United Therapeutics worth $302K as of Q1 2026.
United Therapeutics was a new Two Sigma Securities position in Q1 2026.
United Therapeutics made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #771 holding.
Two Sigma Securities first reported a position in United Therapeutics in Q3 2015 and has held it in 15 quarters since.
Two Sigma Securities's United Therapeutics position peaked at $1.17M in Q3 2025.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.